Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Medical Radiation Sciences|September 10, 2020
Complete clinical response of a neglected cutaneous melanoma with combined radiotherapy and immunotherapy: A case reportPeter Gorayski, Marcin Dzienis
BMJ Case Reports|August 28, 2019
Cetuximab associated dermal filler reactionShivanshan Pathmanathan, Marcin Dzienis
BMJ Case Reports|July 22, 2024
Immune-related colitis presenting with constipationAthanasios Malkopoulos, Robert Mason, Sooraj Pillai, et al.
Internal Medicine Journal|May 7, 2021
Safety and efficacy of telephone clinics during the COVID-19 pandemic in the provision of care for patients with cancerNaomi Watson, Anita Cox, Jasotha Sanmugarajah, et al.
Pigment Cell & Melanoma Research|September 6, 2022
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysisShivanshan Pathmanathan, Hari Babu, Marcin Dzienis, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2025
The safety of extended dosing pembrolizumab when compared to traditional dosing: A review and meta-analysis of retrospective studiesPrasanth Sekar, Ashmitha Ashok Kumar, Ian Hughes, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2015
Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy eraPeter Gorayski, Marcin Dzienis, Matthew Foote, et al.
Current Oncology Reports|March 7, 2023
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary ReviewSam Dowthwaite, James Jackson, Marcin Dzienis, et al.
Advances in Therapy|April 24, 2025
Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment ComparisonMarcin Dzienis, Ali Mojebi, Sam Keeping, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2014
A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinomaMehlika Hazar-Rethinam, Lilia Merida de Long, Orla M Gannon, et al.
Pageof 2